In the first trial with human subjects, it reduced the number of immune system 'killer' cells that attack crucial insulin-producing cells, study shows.
A
"reverse vaccine" that allows people with Type 1 diabetes to produce
their own insulin has passed its first test with human subjects,
according to a new study.
